The FDA has given a thumbs up to Id Core Xt, a molecular-based assay used in transfusion medicine to help assess blood compatibility. The assay can help determine blood donor and patient non-ABO red blood cell types. Id Core Xt is the second molecular assay approved for use in transfusion medicine, and the first to report genotypes as final results.